Advanced search
Publication Cover
Future Oncology Volume 20, 2024 - Issue 3
Submit an article Journal homepage
44
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Prognostication for Surgically Treated Papillary Renal Cell Carcinoma: Which Model is the Optimal Choice?

Michele Maffezzoli1 Medicine & Surgery Department, University of Parma, Parma, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7877-8988
ORCID Icon &
Sebastiano Buti1 Medicine & Surgery Department, University of Parma, Parma, Italy;2 Medical Oncology Unit, University Hospital of Parma, Parma, ItalyORCID Iconhttps://orcid.org/0000-0003-0876-0226
ORCID Icon
Pages 107-111 | Received 17 Sep 2023, Accepted 29 Jan 2024, Published online: 07 Feb 2024

References

  • Bukavina L , Bensalah K , Bray F et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur. Urol. 82(5), 529–542 (2022).
  • Klatte T , Rossi SH , Stewart GD . Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J. Urol. 36(12), 1943–1952 (2018).
  • Angori S , Lobo J , Moch H . Papillary renal cell carcinoma: current and controversial issues. Curr. Opin. Urol. 32(4), 344–351 (2022).
  • Palumbo C , Perri D , Zacchero M et al. Risk of recurrence after nephrectomy: comparison of predictive ability of validated risk models. Urol. Oncol. 40(4), 167.e1–167.e7 (2022).
  • Lin H , Sun Q , Li Z et al. Comparison and validation of different risk models for papillary renal cell carcinoma. Urol. Oncol. 41(8), 358.e1–358.e7 (2023).
  • Hu Y , Xu S , Qi Q et al. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: a population-based study. Front Public Health 10, 989566 (2022).
  • EAU Guidelines . Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
  • Zisman A , Pantuck AJ , Wieder J et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J. Clin. Oncol. 20(23), 4559–4566 (2002).
  • Patard JJ , Kim HL , Lam JS et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J. Clin. Oncol. 22(16), 3316–3322 (2004).
  • Leibovich BC , Lohse CM , Cheville JC et al. Predicting oncologic outcomes in renal cell carcinoma after surgery. Eur. Urol. 73(5), 772–780 (2018).
  • Attalla K , Voss MH , Hakimi AA . Prognostic models in papillary renal cell carcinoma. Ann. Transl. Med. 8(21), 1334 (2020).
  • Piccinelli ML , Barletta F , Tappero S et al. Development and external validation of a novel nomogram predicting cancer-specific mortality-free survival in surgically treated papillary renal cell carcinoma patients. Eur. Urol. Focus 9(5), 799–806 (2023).
  • Klatte T , Gallagher KM , Afferi L et al. The VENUSS prognostic model to predict disease recurrence following surgery for nonmetastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. BMC Med. 17(1), 182 (2019).
  • Erdem S , Capitanio U , Campi R et al. External validation of the VENUSS prognostic model to predict recurrence after surgery in nonmetastatic papillary renal cell carcinoma: a multi-institutional analysis. Urol. Oncol. 40(5), 198.e9–198.e17 (2022).
  • Buti S , Puligandla M , Bersanelli M et al. Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population. (published correction appears in Ann Oncol. 2018 Jul 1;29(7):1604) Ann. Oncol. 28(11), 2747–2753 (2017).
  • Buti S , Karakiewicz PI , Bersanelli M et al. Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: a new tool to predict survival in surgically treated renal cell carcinoma patients [published correction appears in Sci Rep. 2020 Feb 5;10(1):2304]. Sci. Rep. 9(1), 13218 (2019).
  • Piccinelli ML , Tappero S , Cano Garcia C et al. Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma. Eur. Urol. Open Sci. 53, 109–115 (2023).
  • Rosiello G , Larcher A , Fallara G et al. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. Urol. Oncol. 40(6), 271.e19–271.e27 (2022).
  • Yan H , Wei X , Wu A , Sha Y , Li X , Qi F . Nomograms for predicting overall and cancer-specific survival in patients with papillary renal cell carcinoma: a population-based study using SEER database. Transl. Androl. Urol. 9(3), 1146–1158 (2020).
  • Syed JS , Brito J , Pooli A , Boutros PC , Shuch B . Transcriptomics in RCC. Urol. Oncol. 38(10), 742–754 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.